BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11575717)

  • 1. CT-2584 (Cell Therapeutics).
    Bonfil RD
    Curr Opin Investig Drugs; 2001 Mar; 2(3):424-7. PubMed ID: 11575717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GTI-2040. Lorus Therapeutics.
    Orr RM
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1462-6. PubMed ID: 11890366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of phosphatidylcholine biosynthesis is associated with induction of phosphatidylinositol accumulation and cytolysis of neoplastic cell lines.
    Finney RE; Nudelman E; White T; Bursten S; Klein P; Leer LL; Wang N; Waggoner D; Singer JW; Lewis RA
    Cancer Res; 2000 Sep; 60(18):5204-13. PubMed ID: 11016649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OSI-461 (OSI).
    Galmarini CM
    Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin in combination therapy for metastatic breast cancer.
    Perez EA
    Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
    Medina PJ; Goodin S
    Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
    Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
    Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AN-9 (Titan).
    Hobdy E; Murren J
    Curr Opin Investig Drugs; 2004 Jun; 5(6):628-34. PubMed ID: 15242252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TG-4010 Transgene.
    Cohen S; Kaufman HL
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1319-28. PubMed ID: 15648954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT
    Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMS-247550 Bristol-Myers Squibb/GBF.
    Lin N; Brakora K; Seiden M
    Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug evaluation: MGCD-0103, a histone deacetylase inhibitor for the treatment of cancer.
    Kell J
    Curr Opin Investig Drugs; 2007 Jun; 8(6):485-92. PubMed ID: 17621879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug evaluation: Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccine.
    Doehn C; Kausch I; Böhmer T; Sommerauer M; Jocham D
    Curr Opin Mol Ther; 2007 Apr; 9(2):183-9. PubMed ID: 17458173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMS-275291. Bristol-Myers Squibb.
    Poulaki V
    Curr Opin Investig Drugs; 2002 Mar; 3(3):500-4. PubMed ID: 12054103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers.
    Mills DA; Fekrazad HM; Verschraegen CF
    Curr Opin Investig Drugs; 2008 Jun; 9(6):647-57. PubMed ID: 18516764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavopiridol. National Cancer Institute.
    Wang HK
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1149-55. PubMed ID: 11892928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.